Diabetes mellitus is a major health concern, affecting more than 5% of the population. Here
we describe a potential novel therapeutic agent for this disease, FGF-21, which was …

Fibroblast growth factor‐21 (FGF‐21) is a metabolic regulator that can influence glucose and
lipid control in diabetic rodents and primates. We demonstrate that βKlotho is an integral …

Fibroblast growth factor 21 is a novel hormonal regulator with the potential to treat a broad
variety of metabolic abnormalities, such as type 2 diabetes, obesity, hepatic steatosis, and …

Fibroblast growth factor 21 is a member of endocrine FGFs subfamily, along with FGF19 and
FGF23. It is emerging as a novel regulator with beneficial effects on a variety of metabolic …

Erythropoietin (EPO) is a cytokine produced by the kidney whose function is to stimulate red
blood cell production in the bone marrow. Previously, it was shown that the affinity of EPO …

Fibroblast growth factors 19 (FGF19) and 21 (FGF21) have emerged as key regulators of
energy metabolism. Several studies have been conducted to understand the mechanism of …

Biology has taught us that a protein as abundantly made and conserved among species as
Tamm–Horsfall protein (THP or uromodulin) cannot just be a waste product serving no …

Tamm–Horsfall protein (THP), also known as uromodulin, is a kidney-specific protein
produced by cells of the thick ascending limb of the loop of Henle. Although predominantly …

High serum concentrations of kidney-derived protein uromodulin [Tamm-Horsfall protein (THP)]
have recently been shown to be independently associated with low mortality in both …

Abstract Analysis of the immune system in the kidney relies predominantly on flow cytometry.
Although powerful, the process of tissue homogenization necessary for flow cytometry …